View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)

Diabetic nephropathy (DN) is the main cause of the unfavorable prognosis for the life of patients with diabetes mellitus and develops equally often in different types of diabetes. And much more often and faster DN develops in patients with early DM in childhood and puberty. The relevance and importa...

Full description

Bibliographic Details
Published in:	Лечащий Врач
Main Authors:	K. V. Skobeleva, L. V. Tyrtova, I. L. Nikitina, A. S. Olenev
Format:	Article
Language:	Russian
Published:	Open Systems Publication 2021-06-01
Subjects:	diabetes mellitus diabetic nephropathy renin-angiotensin-aldosterone system
Online Access:	https://journal.lvrach.ru/jour/article/view/404

Similar Items

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
by: Yan-Huan Feng, et al.
Published: (2016-01-01)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials
by: Noor Alsalemi, et al.
Published: (2022-04-01)

The evolutionary development of the renin angiotensin aldosterone system and its importance for the survival of the human species
by: Natalia Butt-Hussaim, et al.
Published: (2021-03-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence
by: Bianca Domingues Massolini, et al.
Published: (2020-03-01)

Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
by: Zige Liu, et al.
Published: (2024-01-01)

Efficacy of Shenkang Injection combined with renin-angiotensin-aldosterone system blockers in diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
by: Xinyue Zhang, et al.
Published: (2025-12-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
by: Marat Z. Saidov, et al.
Published: (2019-12-01)

Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus
by: Ilić Vesna, et al.
Published: (2014-01-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)

The role of tissue renin angiotensin aldosterone system in the development of endothelial dysfunction and arterial stiffness
by: Annayya R Aroor, et al.
Published: (2013-10-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
by: Lin Zhang, et al.
Published: (2017-10-01)

A systematic review of nonsynonymous single nucleotide polymorphisms in the renin–angiotensin–aldosterone system
by: Tomasz Rechciński, et al.
Published: (2022-12-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients
by: Yi-Ting Chen, et al.
Published: (2021-01-01)

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
by: Agnese Valentini, et al.
Published: (2025-08-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
by: M. Ekholm, et al.
Published: (2021-06-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum
by: Dana Pop, et al.
Published: (2024-07-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

Revisiting the renin-angiotensin-aldosterone system in the eye: Mechanistic insights and pharmacological targets
by: Francesco Buonfiglio, et al.
Published: (2025-06-01)

Immune Optimization as a Preventive and Therapeutic Adjunct for the Management of Renin–Angiotensin–Aldosterone System Dysfunction Diseases: A Review
by: Michael T. Okafor, et al.
Published: (2024-07-01)

A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
by: Tojo A, et al.
Published: (2016-01-01)

RAAS in diabetic retinopathy: mechanisms and therapies
by: Xin Li, et al.
Published: (2024-06-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Regulation of human salt-sensitivite hypertension by myeloid cell renin-angiotensin-aldosterone system
by: Lale A. Ertuglu, et al.
Published: (2023-07-01)

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
by: Juan José García Martínez, et al.
Published: (2022-11-01)

Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
by: Roberto Pecoits-Filho, et al.
Published: (2025-09-01)

Assessment of Parathyroid Hormone, Vitamin D, Calcium, and Renin-angiotensin-aldosterone System in Nigerians With Hypertension
by: Oloruntoba Ayodele Ekun, et al.
Published: (2024-08-01)

Role of renin–angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients
by: Minako Inoue, et al.
Published: (2018-10-01)